A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.


Updates from The Motley Fool

Latest updates on Meridian Bioscience from Fool.com.


Stock Performance

VIVO vs. S&P 500 | 2 Year Performance
View Interactive VIVO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Meridian Bioscience.
Current Price: $20.40
Prev Close: $20.22
Open: $20.29
Bid: $20.34
Ask: $20.37
Day's Range: $20.13 - $20.42
52wk Range: $16.60 - $21.49
Volume: 30,051
Avg Vol 225,694
Market Cap: $853.45M
P/E (ttm): 24.07
EPS (ttm): $0.84
Div & Yield: $0.80 (4.0%)

Company Rating

What our community thinks about Meridian Bioscience.
CAPS Rating 3 out of 5
 
454 Outperform
11 Underperform
CAPS All Stars
 
74 Outperform
3 Underperform

How do you think Meridian Bioscience will perform against the market?



You pick for Meridian Bioscience is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John A. Kraeutler, CEO

16% Approve

Based on 26 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Meridian Bioscience.

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers